GlassScriptPhysician profile
Michael J Esposito
NPI 1285678755
$1,374.76
in general payments reported to CMS, 2019-2025
14 companies · $384 in 2025
The $384 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $14.46 · 2021: $58.83 · 2022: $643 · 2024: $71.79 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinefrontier, INC. | $643.35 | 2022 | |
| Abbott Laboratories | $181.87 | 2021-2025 | Proclaim |
| Boston Scientific Corporation | $179.03 | 2025 | Intracept |
| Nevro Corp. | $94.75 | 2019 | |
| Saluda Medical Americas, INC. | $73.28 | 2024-2025 | Evoke |
| Smith+Nephew, INC. | $50.61 | 2019-2024 | Acufex, Coblation |
| Stryker Corporation | $47.96 | 2019 | |
| Medtronic, INC. | $18.09 | 2021 | |
| Orthogenrx INC. | $17.65 | 2019 | |
| Curonix LLC | $16.16 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ermi LLC | $14.46 | 2020 | |
| Electronic Waveform Lab, INC. | $13.23 | 2021 | |
| Convatec INC. | $13.21 | 2019 | |
| Stimwave Technologies Incorporated | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Esposito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.